Estimate Hyoscine Butylbromide and Mefenamic Acid by Rp-hplc Method Development and Accelerated Stability Study in Pure and Combine Dosage Form


Estimate Hyoscine Butylbromide and Mefenamic Acid by Rp-HPLC Method Development and Accelerated Stability Study in Pure and Combine Dosage Form


JINAL N. TANDEL *1, JATIN PATEL 1, RASHMIKA R. PATEL 2, SAMIR K. SHAH 3

1Department of Quality Assurance, Sardar Patel College of Pharmacy, Gujarat Technological University,
2Department of pharmacognosy, Sardar Patel College of Pharmacy, Gujarat Technological University.
3Department of pharmacology, Sardar Patel College of Pharmacy, Gujarat Technological University.


Journal of Pharmaceutical Research and Reviews

The aim of the present study was to develop and validate stability indicating HPLC method for simultaneous estimation of Hyoscoine butyl bromide (HBB) and Mefenamic acid (MEF). HPLC method for simultaneous analysis of both drugs was developed and validated according to ICH guideline. Efficient chromatographic separation was achieved on ODS column C18 (250 mm × 4.6 mm, 5 μm) using the optimized mobile phase. Stability indicating assay method was carried out by different stress degradation conditions. In HPLC method, the Retention time for HBB and MEF was 3.21 and 5.07 min using optimized mobile phase potassium dihydrogen phosphate buffer (pH 5.0) and methanol (60:40 % v/v) with a flow rate of 1 ml/min. The multiple wavelength UV detector was set at a 237 nm for measurement of all compound. Quantification based on measuring the peak areas. The degradation of HBB, MEF and Formulation was shown to be highest in alkaline condition. Linearity was observed in concentration range of 1- 3μg/ml and 12.5-37.5 μg/ml for HBB and MEF respectively. All validation parameters were within the acceptable range. Moreover, the % RSD for repeatability, inter and intraday precision was found to be within the range, which reveals that the method is precise. Accuracy study of the drug in marketed preparation also report in the limit. Assay of the dosage form finalized the applicability of this method for estimation of Hyoscine Butylbromide and Mefenamic Acid tablet dosage form.


Keywords: Mefenamic Acid (MEF), Hyoscine Butylbromide (HBB), RP-HPLC, Stability indicating Method,Validation

Free Full-text PDF


How to cite this article:
JINAL N. TANDEL, JATIN PATEL , RASHMIKA R. PATEL, SAMIR K. SHAH. Estimate Hyoscine Butylbromide and Mefenamic Acid by Rp-hplc Method Development and Accelerated Stability Study in Pure and Combine Dosage Form. Journal of Pharmaceutical Research and Reviews, 2018; 2:11.


References:

1 K D Tripathi. Essential of Medical Pharmacology. 6th Edn, Jaypee Brothers Medical Publishers (p) LTD, New Delhi, 2006.
2 “Drug profile for Hyoscine butylbromide”, Sep-2016, www.chemspide r.com/Chemical structure.16736107
3 Goodman & Gilman’s The Pharmacological basis of therapeutics, 11th Edn; 2006
4 “Drug profile for Mefenamic Acid”, Sep-2016, www.chemspider .com/Chemical structure.3904
5 Marwa S. Yonis and Khaleda H. Al-Saidi. Simultaneous Determination of Paracetamol and Hoscine Butylbromide in Binary Mixture using Derrivative Spectrophotometry. Journal of Al-Nahrain University, 2016; 19(1): 56-68.
6 Nouruddin Ali, Mohammed Gamal , Mohammed Abdelkawy. Detemination of Hyoscine Butylebromide and Paracetamol mixture by zero order and first derivative ratio spectrophotometric method. Annalen der Chemischen Forschung, 2014; 2(1): 9-19.
7 Nouruddin Ali, Mohammed Gamal , Mohammed Abdelkawy. Simultaneous Determination of Dipyrone and Hyoscine Butylbromide in Binary Mixture by RP-TLC Spectrodensitometric method. International Journal of Chemical and Analytical Science. 2012; 3(10): 1578-1582
8 Nouruddin Ali, Mohammed Gamal , Mohammed Abdelkawy. Simultaneous Estimation of Hyoscine Butyle Bromide and Paracetamol in their Binary Mixture by RP-HPLC. Arabian Journal of chemistry, 2014; 1-7
9 Dhabarde DM, Hatwar H, Kamble M, Ingole A. Simultaneous Estimation of Hyoscine Butyle Bromide and Paracetamol in their combined Dosage form by RP-HPLC. International, journal of advance In pharma Research, 2014; 5(3): 169-175
10 Saharty YS, Metwally FS, Refaat M. Simutaneous Determination of Hyoscine Butylbromide and Ketoprofen in pharmaceutical preparation by spectrophotometric and
HPLC Method. International journal of analysis, 2007; 90(1): 102-112
11 Nouruddin Ali, Mohammed Gamal , Mohammed Abdelkawy. LC-MS As a stability indicating method for analysis of Hyoscine N-Butylbromide under Stress degradation Condition with identification of Degradation product”, Pharmaceutica analytica acta, 2013; 7: 1-5
12 Mukesh C Sharma. Simultaneous Estimation and Validation of Mefenamic acid and Drotaverine HCl in Tablet dosage form. World Applied Sciences Journal, 2013; 28(9): 1181-1187
13 Dipal Prajapati and Hasumati Raj. Simultaneous Estimation of Mefenamic acid and Dicyclomine by Spectrophotometric method. International Journal of Pharmaceutical science and Research, 2012; 3(10): 3766-3776
14 Subramanian Natesan, Devipriyadharshini Thanasekaran, Venkateshwaran Krishnaswami and Chandrasekar Ponnusamy. Improved RP-HPLC Method for Simultaneous Estimation of Mefenamic acid and Tranexamic acid in Tablet Dosage form. Pharmaceutica analytica acta, 2011; 2(1): 1-6
15 Shrikrishna B, Sugandha M, Nisharani R. Development and Validation of RP-HPLC Method forSimultaneous Estimation of Mefenamic acid and Dicyclomine. Journal of pharmaceutical research, 2014; 13(1): 16-19
16 Dipal Prajapati and Hasumati Raj. Simultaneous Estimation of Mefenamic acid and Dicyclomine by RP HPLC Method. International. journal of Pharmacy and Bio science, 2012; 3(3): 611-625
17 Premanand DC, Sethilkumar KL, Saravan M, Thitumurthy R. Simultaneous Estimation of Mefenamic acid and Drotaverine HCl in Combined Dosage form by RP-HPLC Method. Der Pharma chemical, 2010; 2(5): 170-177
18 Rathinam S, Lakshmi KS. HPTLC Method for Simultaneous Estimation of Mefenamic acid and Camylofin Di HCl in Tablet Dosage form” Int. j. pham. And pharm. Sci., 2014, 6(1), 585-589
19 Pallavi A. Patil, A.R. Umarkar, M.M. Bari and S.D. Barhate. Stability Indicating RP-HPLC Method For Determination of Drotaverine HCL and Mefenamic Acid in Pure and Pharmaceutical Formulation. American Journal of Advanced Drug Delivery, 2015; 3(2): 110-122
20 Bhagyashree R. Dhumal, Kishore P. Bhusari, Madhukar R. Tajne, Mahavir H. Ghante, Nishant S. Jain. Stability indicating method for the determination of Mefenamic acid in pharmaceutical formulation by HPLC. Journal of Applied Pharmaceutical Science, 2014; 4(12): 60-64
21 Indian Pharmacopoiea. Government of india, ministry of health and family welfare, 2014; 2: 1641-1642
22 British pharmacopoeia. vol I-II, Monograph: Medicinal and pharmaceutical science: Mefenamic acid,2013; 1-4
23 USP30-NF25, Pharmacopeial forum:vol. 31(1): 2560
24 ICH Q2 (R1), Validation of Analytical Procedures; Methodology, International Conference on Harmonization, IFPMA, Geneva 1996.
25 ICH Q1A (R2), “Stability Testing of New Drug Substances and Productsˮ, International conference on Harmonization, IFPMA, Geneva, Switzerland, 2003.